Husseini K. Manji

39.5k total citations · 12 hit papers
222 papers, 27.7k citations indexed

About

Husseini K. Manji is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, Husseini K. Manji has authored 222 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Cellular and Molecular Neuroscience, 74 papers in Psychiatry and Mental health and 68 papers in Biological Psychiatry. Recurrent topics in Husseini K. Manji's work include Bipolar Disorder and Treatment (70 papers), Neuroscience and Neuropharmacology Research (69 papers) and Tryptophan and brain disorders (68 papers). Husseini K. Manji is often cited by papers focused on Bipolar Disorder and Treatment (70 papers), Neuroscience and Neuropharmacology Research (69 papers) and Tryptophan and brain disorders (68 papers). Husseini K. Manji collaborates with scholars based in United States, United Kingdom and Czechia. Husseini K. Manji's co-authors include Carlos A. Zarate, Dennis S. Charney, Wayne C. Drevets, David A. Luckenbaugh, Jaskaran Singh, Todd D. Gould, Nancy E. Brutsché, Keri Martinowich, Rodrigo Machado‐Vieira and Jing Du and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Husseini K. Manji

217 papers receiving 27.0k citations

Hit Papers

A Randomized Trial of an N-methyl-D-aspartate Antagonist ... 2001 2026 2009 2017 2006 2007 2007 2001 2004 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
    2006 2.7k citations Carlos A. Zarate, Jaskaran Singh et al. profile →
  2. New insights into BDNF function in depression and anxiety
    2007 969 citations Husseini K. Manji et al. Nature Neuroscience profile →
  3. Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
    2007 921 citations Sungho Maeng, Carlos A. Zarate et al. Biological Psychiatry profile →
  4. The cellular neurobiology of depression
    2001 903 citations Husseini K. Manji, Wayne C. Drevets et al. profile →
  5. Discovering Endophenotypes for Major Depression
    2004 864 citations Wayne C. Drevets, Husseini K. Manji et al. profile →
  6. A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
    2010 734 citations Nancy E. Brutsché, David A. Luckenbaugh et al. profile →
  7. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
    2008 683 citations Gerard Sanacora, Carlos A. Zarate et al. profile →
  8. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
    2017 489 citations Ella Daly, Jaskaran Singh et al. profile →
  9. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
    2019 483 citations Vanina Popova, Ella Daly et al. American Journal of Psychiatry profile →
  10. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
    2018 357 citations Carla M. Canuso, Jaskaran Singh et al. American Journal of Psychiatry profile →
  11. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
    2019 297 citations Maggie Fedgchin, Madhukar H. Trivedi et al. The International Journal of Neuropsychopharmacology profile →
  12. Immune targets for therapeutic development in depression: towards precision medicine
    2022 202 citations Wayne C. Drevets, Husseini K. Manji et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Husseini K. Manji United States 88 9.9k 9.9k 9.6k 7.0k 5.5k 222 27.7k
Carlos A. Zarate United States 99 15.1k 1.5× 10.4k 1.1× 17.0k 1.8× 10.6k 1.5× 3.4k 0.6× 481 35.6k
Gerard Sanacora United States 72 9.0k 0.9× 8.6k 0.9× 8.3k 0.9× 3.1k 0.4× 2.6k 0.5× 192 21.6k
Flávio Kapczinski Brazil 87 8.4k 0.9× 4.0k 0.4× 3.0k 0.3× 14.6k 2.1× 2.7k 0.5× 592 28.5k
Wayne C. Drevets United States 109 9.7k 1.0× 10.0k 1.0× 9.2k 1.0× 10.8k 1.5× 3.8k 0.7× 352 47.0k
Todd D. Gould United States 58 3.8k 0.4× 4.8k 0.5× 3.6k 0.4× 3.9k 0.6× 3.5k 0.6× 141 15.6k
Alessandro Serretti Italy 75 4.4k 0.4× 4.3k 0.4× 5.8k 0.6× 9.0k 1.3× 3.4k 0.6× 738 26.4k
Oliver Howes United Kingdom 85 5.3k 0.5× 6.8k 0.7× 3.0k 0.3× 11.8k 1.7× 4.4k 0.8× 435 27.7k
Alan F. Schatzberg United States 87 5.9k 0.6× 3.3k 0.3× 7.4k 0.8× 6.8k 1.0× 2.8k 0.5× 421 34.1k
David A. Luckenbaugh United States 72 6.9k 0.7× 4.7k 0.5× 8.2k 0.9× 6.0k 0.9× 1.2k 0.2× 159 17.9k
Robert M. Post United States 106 3.4k 0.3× 6.9k 0.7× 4.1k 0.4× 20.1k 2.9× 3.0k 0.5× 586 37.3k

Countries citing papers authored by Husseini K. Manji

Since Specialization
Citations

This map shows the geographic impact of Husseini K. Manji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Husseini K. Manji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Husseini K. Manji more than expected).

Fields of papers citing papers by Husseini K. Manji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Husseini K. Manji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Husseini K. Manji. The network helps show where Husseini K. Manji may publish in the future.

Co-authorship network of co-authors of Husseini K. Manji

This figure shows the co-authorship network connecting the top 25 collaborators of Husseini K. Manji. A scholar is included among the top collaborators of Husseini K. Manji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Husseini K. Manji. Husseini K. Manji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Dong‐Jing, Dawn F. Ionescu, Xiang Li, et al.. (2020). Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent. The Journal of Clinical Psychiatry. 81(3). 148 indexed citations
2.
Morrison, Robert M., Jaskaran Singh, Ella Daly, et al.. (2019). Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies. European Neuropsychopharmacology. 29. 1 indexed citations
3.
Breen, Gerome, Qingqin S. Li, Bryan L. Roth, et al.. (2016). Translating genome-wide association findings into new therapeutics for psychiatry. Nature Neuroscience. 19(11). 1392–1396. 73 indexed citations
4.
Bredt, David S., et al.. (2015). Translating depression biomarkers for improved targeted therapies. Neuroscience & Biobehavioral Reviews. 59. 1–15. 16 indexed citations
5.
Duncan, Wallace C., Simone Sarasso, Fabio Ferrarelli, et al.. (2012). Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. The International Journal of Neuropsychopharmacology. 16(2). 301–311. 177 indexed citations
6.
Savitz, Jonathan, Allison C. Nugent, Jonathan P. Roiser, et al.. (2010). Habenula Volume in Bipolar Disorder and Major Depressive Disorder: A High-Resolution Magnetic Resonance Imaging Study. Biological Psychiatry. 69(4). 336–343. 146 indexed citations
7.
Du, Jing, Yanling Wei, Lidong Liu, et al.. (2010). A kinesin signaling complex mediates the ability of GSK-3β to affect mood-associated behaviors. Proceedings of the National Academy of Sciences. 107(25). 11573–11578. 100 indexed citations
8.
Bachmann, Rosilla, Yun Wang, Peixiong Yuan, et al.. (2009). Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. The International Journal of Neuropsychopharmacology. 12(6). 805–805. 129 indexed citations
9.
Malkesman, Oz, María Luisa Scattoni, Daniel Paredes, et al.. (2009). The Female Urine Sniffing Test: A Novel Approach for Assessing Reward-Seeking Behavior in Rodents. Biological Psychiatry. 67(9). 864–871. 158 indexed citations
10.
Gelenberg, Alan J., Michael E. Thase, Roger E. Meyer, et al.. (2008). The History and Current State of Antidepressant Clinical Trial Design. The Journal of Clinical Psychiatry. 69(10). 1513–1528. 59 indexed citations
11.
Maeng, Sungho, Joshua Hunsberger, Brandon L. Pearson, et al.. (2008). BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments. Proceedings of the National Academy of Sciences. 105(25). 8766–8771. 52 indexed citations
12.
Shaltiel, Galit, Sungho Maeng, Oz Malkesman, et al.. (2008). Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Molecular Psychiatry. 13(9). 858–872. 136 indexed citations
13.
Laje, Gonzalo, Silvia Paddock, Husseini K. Manji, et al.. (2007). Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression. American Journal of Psychiatry. 164(10). 1530–1538. 158 indexed citations
14.
Wood, Stephen J., Gregor Berger, Margaret Dell’Olio, et al.. (2007). Effects of low dose lithium on hippocampal neuropathology in people at ultra-high risk for psychosis. Biological Psychiatry. 61(8). 5 indexed citations
15.
McMahon, Francis J., Silvia Buervenich, Dennis S. Charney, et al.. (2006). Variation in the Gene Encoding the Serotonin 2A Receptor Is Associated with Outcome of Antidepressant Treatment. The American Journal of Human Genetics. 78(5). 804–814. 343 indexed citations
16.
17.
Neumeister, Alexander, Peixiong Yuan, Theresa Young, et al.. (2005). Effects of Tryptophan Depletion on Serum Levels of Brain-Derived Neurotrophic Factor in Unmedicated Patients With Remitted Depression and Healthy Subjects. American Journal of Psychiatry. 162(4). 805–807. 43 indexed citations
18.
Manji, Husseini K.. (2001). Neuroplasticity and cellular resilence in mood disorder. Acta Neurobiologiae Experimentalis. 61(3).
19.
Manji, Husseini K., Gregory J. Moore, & Guang Chen. (1999). Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? - Unmasking the executioner. Biological Psychiatry. 7(46). 929–940. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos A. Zarate Breakdown of academic impact, for papers by Gerard Sanacora Breakdown of academic impact, for papers by Flávio Kapczinski Breakdown of academic impact, for papers by Wayne C. Drevets Breakdown of academic impact, for papers by Todd D. Gould Breakdown of academic impact, for papers by Alessandro Serretti Breakdown of academic impact, for papers by Oliver Howes Breakdown of academic impact, for papers by Alan F. Schatzberg Breakdown of academic impact, for papers by David A. Luckenbaugh Breakdown of academic impact, for papers by Robert M. Post
Rankless by CCL
2026